Further experience with polydioxanone airway stents in children
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.27056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Rocío Morante-Valverde und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Surgery Division & Pediatric Airway Unit, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Polydioxanone, Stents, Airway Obstruction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: None.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
The aims of this study were to update our experience with biodegradable polydioxanone (PDO) airway stents in children, focusing on effectiveness and safety, and to analyze the factors involved in the different outcomes observed. Materials and Methods Retrospective study of patients managed with PDO stents from 2012 to 2023. Variables collected: demographics, comorbidities, indication, clinical baseline, stent size, location, complications, clinical outcome, and time of follow‐up. Statistical analyses were performed to detect the eventual contribution of variables in the different outcomes observed.
Results
Fifty‐four PDO stents were placed in 26 patients (median age, 4 months). All showed severe symptoms of central airway obstruction due to tracheomalacia in nine patients, bronchomalacia five, tracheobronchomalacia 10, and tracheal stenosis two. Stent placement was uneventful in every case: 29 stents in the trachea and 25 in the main bronchi. 53.8% of patients needed successive stenting, and all exhibited comorbidities. Complete clinical resolution was observed in eight cases (30.7%), partial improvement in 13 (50%), unchanged in 4 (15.3%), and worsened in one. Age had a significant positive impact on outcome (6 vs. 3 months; p = 0.024). Additionally, smaller stents were associated with a better outcome (20 vs. 26 mm; p = 0.044). Granulation tissue was the most frequent complication (34.6%). Five patients (19.2%) died due to severe comorbidities, follow‐up was complete in survivors (median, 58 months).
Conclusions
PDO stents are safe and effective when dealing with severe tracheobronchial obstruction. Stent‐related granulation tissue continues to be a relevant matter of concern. This issue, together with increased degradation times, deserves further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Surgery Division & Pediatric Airway Unit, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.
- Division of Pediatrics, Pulmonary Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
- Pediatric Anesthesiology Division, Hospital Universitario 12 de Octubre, Madrid, Spain.
- Pediatric Intensive Care Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
ORCID-Profile: María López Díaz, Victoria Ramos, Juan L Antón-Pacheco
Förderung
- None
Zitieren
APA
Morante-Valverde, R., Díaz, M. L., Luna-Paredes, M. C., Proaño, S., Castellano, C., Méndez, M. D., Ramos, V., & Antón-Pacheco, J. L. (2024). Further experience with polydioxanone airway stents in children. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27056
Vancouver
Morante-Valverde R, Díaz ML, Luna-Paredes MC, Proaño S, Castellano C, Méndez MD, et al. Further experience with polydioxanone airway stents in children. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27056
BibTeX
@article{MoranteValverde2024,
author = {Morante-Valverde, Rocío and Díaz, María López and Luna-Paredes, Mª Carmen and Proaño, Sara and Castellano, Cecilia and Méndez, Mª Dolores and Ramos, Victoria and Antón-Pacheco, Juan L},
title = {Further experience with polydioxanone airway stents in children},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.27056}
}
EUVIMED